Huntingdon Life Sciences and Harlan Laboratories announce new equity funding

21-Jul-2015 - United Kingdom

Huntingdon Life Sciences (HLS) and Harlan Laboratories, soon to be called Envigo, announced that a group of institutional investors has committed up to $125 million in a minority equity financing that can be used to fund future growth initiatives.

Brian Cass, CEO, commented: “We recently announced our rebranding of the Company to Envigo as we complete the integration of HLS and Harlan to broaden the support we provide to life science research. This equity investment of up to $125 million validates the success of that integration and further strengthens the Company’s balance sheet to pursue additional organic and strategic investments.  We look forward to leveraging the resources of the investor group as we continue to grow Envigo and enhance our market leading position.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances